about
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control studyDeterminants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individualsPatterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer.Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area.Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran.Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma.Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran.Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habitGolestan cohort study of oesophageal cancer: feasibility and first results.Epidemiologic features of upper gastrointestinal tract cancers in Northeastern IranOpium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran.A U-shaped relationship between haematocrit and mortality in a large prospective cohort study.Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern IranInoperable esophageal cancer and outcome of palliative care.Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area.Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.Determinants of healthcare utilisation and predictors of outcome in colorectal cancer patients from Northern Iran.Food preparation methods, drinking water source, and esophageal squamous cell carcinoma in the high-risk area of Golestan, Northeast Iran.Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice.Role of silis in esophageal cancer.A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.The association of increased stomach wall radiotracer uptake with prolonged use of omeprazole capsules on myocardial perfusion imaging (MPI) using 99mTc-sestamibi SPECT.Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran.Opium use and risk of mortality from digestive diseases: a prospective cohort study.Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer.Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma.Serum leptin levels and irritable bowel syndrome: a new hypothesis.Depressive mood and disease activity in inflammatory bowel disease.Soils selenium level and esophageal cancer: an ecological study in a high risk area for esophageal cancer.False-positive defects on exercise 99mTc-sestamibi SPECT imaging, but not on dipyridamole 99mTc-sestamibi SPECT imaging, in a patient with right bundle branch block (RBBB).Pictogram use was validated for estimating individual's body mass indexDeclining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: A retrospective cancer surveillanceIncidence and age distribution of colorectal cancer in Iran: Results of a population-based cancer registryAflatoxin contamination of wheat flour and the risk of esophageal cancer in a high risk area in IranThe association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: a preliminary studyMyocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosusScintigraphic parameters with emphasis on perfusion appraisal in rest 99mTc-sestamibi SPECT in the recovery of myocardial function after thrombolytic therapy in patients with ST elevation myocardial infarction (STEMI)
P50
Q28396223-180373CE-AB01-4143-8BCE-AB9505481FACQ28658745-12A552C7-618C-4000-8877-BF945A229F3CQ33552511-3C36C76A-8934-4C15-BBE7-522A132965CBQ33979719-D808AE71-1158-499A-9992-8B56433698EEQ34686979-4F1C0EC7-F27E-4B28-BF5A-B5C6731FB7FDQ34988742-523C9004-EB2F-4857-9D60-E7C73443FF9EQ35894600-A2B9C427-4F6C-4BF4-8B95-2A568C30D7F9Q36184216-F1E9C7C3-0A5E-45F4-B853-08E6B1C6A038Q36615753-2A918BF4-870F-49D6-A934-5BCB2F8F9A4BQ36694883-5EB98455-2611-4383-9CEB-781FD7E50F50Q36696475-B5C75B66-9945-453E-8A24-041E3A205DBFQ36749452-A78873C1-2EC4-4133-B775-9040E323B384Q37005294-AE0C0CFD-05A9-4CC2-BC30-42B43659AC16Q37284826-B84249DE-1734-4C36-90F3-CD91A2687474Q37287983-953C5D36-162B-40B1-9FFA-CC1B1ADF6647Q39084315-6A751D7D-6FEA-4A7B-823D-ADD73952613CQ40265791-E5AB92C0-D15F-433F-BDE0-1E70DAAF7182Q41103928-38D5EC79-3786-4D8B-81C3-63A6B3FDEB00Q42223120-A3581479-81D7-4DAE-9882-0B5FC44F970EQ42538434-FE77E3F5-4AEB-41E4-8378-0EB0074A182EQ42960836-9EB70B75-3F01-4B4C-BEAE-9A9BD1270C67Q43726325-9D68B2C9-9004-4E56-8E90-EE83EA4C4E79Q44035129-F5107ADD-AE28-4FC0-980E-FD63A3F60789Q46026083-E8A57BAF-4751-406B-ACAE-80F40005D615Q46221697-B622480D-74BD-49BB-BC93-00384883E28DQ46933354-65F446A4-4DF0-4762-B06D-F531EC073B29Q47870583-253D8869-68AD-464F-A0DD-5B4D30A1FBE9Q47928993-E3E88BA4-1AB5-4748-B832-055657B4CA92Q48585894-8A9F96F3-174C-4800-8143-CC5AA92850BDQ51175197-222C1051-8D21-4F2F-B7BB-E6CDE2DB7479Q53109288-A61A7345-28D0-4412-A4DE-53112BCD700BQ57157227-A0387013-63D0-4F1C-AE50-14D74C872451Q57157348-35C6F9DD-C850-46DA-A2E6-DD5A7766D3DDQ57157357-5E34CB26-1043-4698-A2D8-251F15324264Q58440642-D2B72166-C6BD-43C8-B35B-1ED815B58CE3Q58618876-E059F962-CE1E-4251-85CF-F255481ABFFBQ58618881-5586125D-DFFC-402A-82E2-793880B6C12FQ58618884-9DD4E1BD-D824-401F-96B9-B3947A3CF5D6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shahryar Semnani
@ast
Shahryar Semnani
@en
Shahryar Semnani
@es
Shahryar Semnani
@nl
Shahryar Semnani
@sl
type
label
Shahryar Semnani
@ast
Shahryar Semnani
@en
Shahryar Semnani
@es
Shahryar Semnani
@nl
Shahryar Semnani
@sl
prefLabel
Shahryar Semnani
@ast
Shahryar Semnani
@en
Shahryar Semnani
@es
Shahryar Semnani
@nl
Shahryar Semnani
@sl
P1053
N-2270-2016
P106
P1153
35847212100
P21
P31
P3829
P496
0000-0002-8768-6142
P569
2000-01-01T00:00:00Z